GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/7/2026 6:12:50 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $1,976,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/8/2026 8:44:01 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $2,468,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/30/2026 5:56:26 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $1,404,000 | Assets $2,931,000 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 12/5/2025 4:02:26 PM | View | Proxy | SEC | Y 2024 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/13/2025 4:24:14 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $3,725,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/14/2025 4:26:24 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $1,404,000 | Assets $4,161,000 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/15/2025 4:13:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $3,594,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/31/2025 4:27:23 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $2,672,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/14/2024 4:30:37 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $2,625,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/14/2024 4:15:08 PM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $2,625,000 | Export Earnings Model | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/9/2024 4:28:16 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $4,988,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/9/2024 4:14:29 PM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $4,988,000 | Export Earnings Model | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/15/2024 4:38:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $3,310,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/15/2024 9:03:34 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $3,310,000 | Export Earnings Model | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/6/2024 6:11:48 AM | View | Proxy | SEC | Y 2023 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/18/2024 4:59:55 PM | View | Proxy | SEC | Y 2023 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/18/2024 4:28:05 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $1,850,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/18/2024 4:11:32 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $1,850,000 | Export Earnings Model | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 1/29/2024 8:01:00 AM | View | Proxy | SEC | Y 2023 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/13/2023 4:27:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $502,000 | EPS $0.06 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/13/2023 4:14:54 PM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $502,000 | EPS $0.06 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/11/2023 4:36:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $1,666,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/10/2023 4:22:50 PM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $1,666,000 | Export Earnings Model | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/12/2023 4:33:07 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $8,447,000 | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/12/2023 8:36:22 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $8,447,000 | Export Earnings Model | |||
| AVENUE THERAPEUTICS, INC. (ATXI) | 4/28/2023 4:13:57 PM | View | Proxy | SEC | Y 2022 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/31/2023 4:38:23 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $6,845,000 | EPS -$1.63 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/30/2023 4:11:39 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $6,845,000 | EPS $1.23 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/18/2022 4:21:34 PM | View | Proxy | SEC | Y 2021 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/10/2022 4:48:49 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $575,000 | EPS -$0.45 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/10/2022 4:38:49 PM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $575,000 | EPS -$0.45 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/22/2022 4:31:13 PM | View | Proxy | SEC | Y 2021 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/15/2022 5:28:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $1,005,000 | EPS -$0.03 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/16/2022 4:40:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $1,956,000 | EPS -$0.14 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/25/2022 4:43:17 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $3,960,000 | EPS -$0.22 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/23/2021 4:08:39 PM | View | Proxy | SEC | Y 2020 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/15/2021 9:10:49 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $688,000 | EPS -$0.79 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/16/2021 11:22:16 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $1,191,000 | EPS -$0.06 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/17/2021 9:13:10 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $1,944,000 | EPS -$0.06 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/31/2021 8:13:10 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $3,245,000 | EPS -$0.31 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/4/2020 5:14:59 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $4,352,000 | EPS -$0.06 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/14/2020 5:25:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $5,331,000 | EPS -$0.11 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/14/2020 8:30:45 AM | View | Financials | Earnings | SEC | 2Q 2020 | Assets $5,331,000 | EPS -$0.11 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/11/2020 9:41:57 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $6,696,000 | EPS -$0.08 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/11/2020 9:01:35 AM | View | Financials | Earnings | SEC | 1Q 2020 | Assets $6,696,000 | EPS -$0.08 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 4/29/2020 9:01:41 AM | View | Proxy | SEC | Y 2019 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/30/2020 4:14:36 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $8,915,000 | EPS -$1.65 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/30/2020 9:03:56 AM | View | Financials | Earnings | SEC | Y 2019 | Assets $8,915,000 | EPS -$0.33 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/13/2019 5:01:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $13,878,000 | EPS -$0.14 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/4/2019 9:02:23 AM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $13,878,000 | EPS -$0.14 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/14/2019 10:03:04 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $15,677,000 | EPS -$0.43 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/14/2019 9:00:59 AM | View | Financials | Earnings | SEC | 2Q 2019 | Assets $15,677,000 | EPS -$0.43 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/13/2019 2:06:49 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $29,763,000 | EPS -$0.82 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/13/2019 9:01:48 AM | View | Financials | Earnings | SEC | 1Q 2019 | Assets $29,763,000 | EPS -$0.82 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 4/30/2019 3:12:38 PM | View | Proxy | SEC | Y 2018 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/12/2019 5:49:07 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $4,525,000 | EPS -$2.10 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/12/2019 9:18:18 AM | View | Financials | Earnings | SEC | Y 2018 | Assets $4,525,000 | EPS -$0.37 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 12/21/2018 12:24:54 PM | View | Proxy | SEC | Y 2017 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/14/2018 5:07:25 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $5,263,000 | EPS -$0.25 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/14/2018 4:33:56 PM | View | Financials | Earnings | SEC | 3Q 2018 | Assets $5,263,000 | EPS -$0.25 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/14/2018 9:26:28 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $9,436,000 | EPS -$0.45 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/3/2018 9:46:45 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $15,273,000 | EPS -$1.03 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/3/2018 8:01:08 AM | View | Financials | Earnings | SEC | 1Q 2018 | Assets $15,273,000 | EPS -$1.03 | Export Earnings Model | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 4/30/2018 7:03:34 AM | View | Proxy | SEC | Y 2017 | ||||||
| AVENUE THERAPEUTICS, INC. (ATXI) | 3/1/2018 5:47:50 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $22,170,000 | EPS -$1.85 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 11/9/2017 8:47:04 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $26,176,000 | EPS -$0.30 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 8/11/2017 4:14:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $34,705,000 | EPS -$0.70 | ||
| AVENUE THERAPEUTICS, INC. (ATXI) | 5/12/2017 5:36:28 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $234,000 | EPS -$0.22 |